BioTime Inc (NYSE MKT LLC:BTX)

4.25
Delayed Data
As of Mar 02
 +0.05 / +1.19%
Today’s Change
2.21
Today|||52-Week Range
4.64
+13.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-11.2M-16.5M-21.4M-43.9M
 
 
 
 
 
Depreciation1.7M3.1M2.8M4.0M
 
 
 
 
 
Total Other Cash Flow2.2M-177.1K-1.6M10.9M
 
 
 
 
 
Funds From Operations-7.3M-13.6M-20.1M-32.3M
 
 
 
 
 
Funds From/For Other Operating Expenses447.8K-26.1K-468.0K-2.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-7.7M-13.6M-19.7M-29.5M
 
 
 
 
 
 
InvestingDecrease In Investments3.7M0.00292.4K0.00
 
 
 
Capital Expenditures-220.8K-960.3K-400.8K-2.3M
 
 
 
 
 
Fixed Asset Disposal148.8K5.9K4.5K30.9K
 
 
 
 
 
Net Assets From Acquisitions 0.00-246.9K0.00-978.1K
 
 
 
Other Investing - Uses-467.6K-1.5K-764.00-441.2K
 
 
 
 
 
Other Investing - Sources3.9K10.00----
 
 
 
Net Cash Flow Investing3.2M-1.2M-104.7K-3.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale25.8M3.9M1.9M34.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing25.8M3.9M1.9M34.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-96.1K-178.8K8.9K56.1K
 
 
 
 
 
 
Net Change In Cash21.2M-10.9M-17.9M1.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account